Estrella Immunopharma
ESLA
ESLA
19 hedge funds and large institutions have $32.4M invested in Estrella Immunopharma in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
+3
Holders Change %
+18.75%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
HHGC
Hunting Hill Global Capital
New York
|
$2.87M |
2 |
Nomura Holdings
Tokyo,
Japan
|
$1.95M |
3 |
LA
Linden Advisors
New York
|
$1.64M |
4 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
$901K |
5 |
KIM
Karpus Investment Management
Pittsford,
New York
|
$8.59M |
Top Sellers
1 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
$0 |
2 |
D.E. Shaw & Co
New York
|
$0 |
3 |
MSU
Mizuho Securities USA
New York
|
$0 |